{"title":"复发性尿路感染管理中用于预防的非抗菌剂费用。","authors":"Arun Joshi, Lazaros Tzelves, Patrick Juliebø-Jones, Wissam Kamal, Anil Shrestha, Bhaskar Somani","doi":"10.1177/00369330251355285","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveThe aim of this paper was to look at the cost of the different non-antimicrobials available for the management of recurrent UTIs, and to compare these to the antimicrobials currently recommended for prophylaxis in the United Kingdom.MethodsFive non-antimicrobials (D-mannose, Probiotics/lactobacillus, Methenamine Hippurate, Oestrogens and Cranberry) and four antimicrobials (prophylactic dose Trimethoprim, Nitrofurantoin, Amoxicillin and Cefalexin) were included. The cost for 6 months of prophylactic treatment was calculated for each, with the median and range included for the non-prescription products.ResultsFor a 6-month duration, the median cost of Vaginal oestrogen, Cranberry, Methenamine Hippurate, Probiotics and D-mannose was £22.04, £55.95, £100.44, £139.5 and £158.40 respectively. Vaginal oestrogens were the cheapest non-antimicrobial management option with D-mannose being the most expensive. Trimethoprim was the cheapest of the antimicrobials for 6 months of prophylaxis (£5.08), followed by Cefalexin (£7.97), Amoxicillin (£10.71) and Nitrofurantoin (£16.32).ConclusionThe cost of antimicrobial management options for the prophylaxis of UTIs was found to be generally cheaper across the board, in comparison to non-antimicrobial products. However, the continuing public health crisis with regards to overprescribing of antimicrobials, growing resistance and the need for antimicrobial stewardship makes non-antimicrobials an ever-important consideration.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":" ","pages":"369330251355285"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost of non-antimicrobials for prophylaxis in the management of recurrent UTIs.\",\"authors\":\"Arun Joshi, Lazaros Tzelves, Patrick Juliebø-Jones, Wissam Kamal, Anil Shrestha, Bhaskar Somani\",\"doi\":\"10.1177/00369330251355285\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ObjectiveThe aim of this paper was to look at the cost of the different non-antimicrobials available for the management of recurrent UTIs, and to compare these to the antimicrobials currently recommended for prophylaxis in the United Kingdom.MethodsFive non-antimicrobials (D-mannose, Probiotics/lactobacillus, Methenamine Hippurate, Oestrogens and Cranberry) and four antimicrobials (prophylactic dose Trimethoprim, Nitrofurantoin, Amoxicillin and Cefalexin) were included. The cost for 6 months of prophylactic treatment was calculated for each, with the median and range included for the non-prescription products.ResultsFor a 6-month duration, the median cost of Vaginal oestrogen, Cranberry, Methenamine Hippurate, Probiotics and D-mannose was £22.04, £55.95, £100.44, £139.5 and £158.40 respectively. Vaginal oestrogens were the cheapest non-antimicrobial management option with D-mannose being the most expensive. Trimethoprim was the cheapest of the antimicrobials for 6 months of prophylaxis (£5.08), followed by Cefalexin (£7.97), Amoxicillin (£10.71) and Nitrofurantoin (£16.32).ConclusionThe cost of antimicrobial management options for the prophylaxis of UTIs was found to be generally cheaper across the board, in comparison to non-antimicrobial products. However, the continuing public health crisis with regards to overprescribing of antimicrobials, growing resistance and the need for antimicrobial stewardship makes non-antimicrobials an ever-important consideration.</p>\",\"PeriodicalId\":21683,\"journal\":{\"name\":\"Scottish Medical Journal\",\"volume\":\" \",\"pages\":\"369330251355285\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scottish Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/00369330251355285\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scottish Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00369330251355285","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Cost of non-antimicrobials for prophylaxis in the management of recurrent UTIs.
ObjectiveThe aim of this paper was to look at the cost of the different non-antimicrobials available for the management of recurrent UTIs, and to compare these to the antimicrobials currently recommended for prophylaxis in the United Kingdom.MethodsFive non-antimicrobials (D-mannose, Probiotics/lactobacillus, Methenamine Hippurate, Oestrogens and Cranberry) and four antimicrobials (prophylactic dose Trimethoprim, Nitrofurantoin, Amoxicillin and Cefalexin) were included. The cost for 6 months of prophylactic treatment was calculated for each, with the median and range included for the non-prescription products.ResultsFor a 6-month duration, the median cost of Vaginal oestrogen, Cranberry, Methenamine Hippurate, Probiotics and D-mannose was £22.04, £55.95, £100.44, £139.5 and £158.40 respectively. Vaginal oestrogens were the cheapest non-antimicrobial management option with D-mannose being the most expensive. Trimethoprim was the cheapest of the antimicrobials for 6 months of prophylaxis (£5.08), followed by Cefalexin (£7.97), Amoxicillin (£10.71) and Nitrofurantoin (£16.32).ConclusionThe cost of antimicrobial management options for the prophylaxis of UTIs was found to be generally cheaper across the board, in comparison to non-antimicrobial products. However, the continuing public health crisis with regards to overprescribing of antimicrobials, growing resistance and the need for antimicrobial stewardship makes non-antimicrobials an ever-important consideration.
期刊介绍:
A unique international information source for the latest news and issues concerning the Scottish medical community. Contributions are drawn from Scotland and its medical institutions, through an array of international authors. In addition to original papers, Scottish Medical Journal publishes commissioned educational review articles, case reports, historical articles, and sponsoring society abstracts.This journal is a member of the Committee on Publications Ethics (COPE).